ID

19632

Beschreibung

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00533936

Link

https://clinicaltrials.gov/show/NCT00533936

Stichworte

Versionen (1)
  1. 17.01.17 17.01.17 -
Hochgeladen am

17. Januar 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00533936

Englisch

Eligibility Breast Cancer NCT00533936

1 Formulare  
Criteria
Beschreibung

Criteria

histologically confirmed invasive breast cancer by needle biopsy
Beschreibung

Invasive carcinoma of breast Needle biopsy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0005560
diagnosed within the past 4 weeks
Beschreibung

Diagnosis Timepoint

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C2348792
clinical stage iib, iiia, iiib, or iiic disease
Beschreibung

Disease TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
palpable adenopathies present
Beschreibung

Lymphadenopathy Palpable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0497156
UMLS CUI [1,2]
C0522499
her2/neu-positive disease, as evidenced by either of the following:
Beschreibung

HER2-positive carcinoma of breast Evidence of

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1960398
UMLS CUI [1,2]
C0332120
her2/neu overexpression (3+) by immunohistochemistry (ihc)
Beschreibung

ERBB2 Protein Overexpression Immunohistochemistry

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1515560
UMLS CUI [1,2]
C0021044
her2/neu amplification by fluorescence in situ hybridization (fish)
Beschreibung

HER2 gene amplification Fluorescent in Situ Hybridization

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512127
UMLS CUI [1,2]
C0162789
no metastatic disease by chest radiography, hepatic ultrasound, and bone scan (metastatic bone series if no nuclear medicine is available)
Beschreibung

Neoplasm Metastasis Plain chest X-ray | Ultrasonography of liver | Radioisotope scan of bone

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0039985
UMLS CUI [2]
C0412534
UMLS CUI [3]
C0203668
hormone receptor status:
Beschreibung

Hormone Receptor Status

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
estrogen receptor and/or progesterone receptor status known
Beschreibung

Estrogen Receptor Status Known | Progesterone Receptor Status Known

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0034804
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205309
UMLS CUI [2,1]
C0034833
UMLS CUI [2,2]
C0449438
UMLS CUI [2,3]
C0205309
patient characteristics:
Beschreibung

Client Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
premenopausal or postmenopausal
Beschreibung

Premenopausal state | Postmenopausal state

Datentyp

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C0232970
who performance status 0-2
Beschreibung

WHO performance status scale

Datentyp

boolean

Alias
UMLS CUI [1]
C1298650
not pregnant or nursing
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
normal hepatic, renal, and hematological function
Beschreibung

Liver function | Renal function | Hematologic function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0221130
lvef ≥ 55% by nuclear medicine study or echocardiogram
Beschreibung

Left ventricular ejection fraction Nuclear medicine procedure | Echocardiography

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0203634
UMLS CUI [2]
C0013516
no prior history of cancer, except carcinoma in situ of the cervix
Beschreibung

Malignant Neoplasms | Carcinoma in situ of uterine cervix

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0851140
no allergic reaction or hypersensitivity to paclitaxel and/or trastuzumab (herceptin®)
Beschreibung

Paclitaxel allergy | Hypersensitivity trastuzumab | Hypersensitivity Herceptin

Datentyp

boolean

Alias
UMLS CUI [1]
C0570707
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0728747
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0338204
prior concurrent therapy:
Beschreibung

Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
no prior cancer therapy
Beschreibung

cancer treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0920425
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT00533936

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Invasive carcinoma of breast Needle biopsy
Item
histologically confirmed invasive breast cancer by needle biopsy
boolean
C0853879 (UMLS CUI [1,1])
C0005560 (UMLS CUI [1,2])
Diagnosis Timepoint
Item
diagnosed within the past 4 weeks
boolean
C0011900 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
Disease TNM clinical staging
Item
clinical stage iib, iiia, iiib, or iiic disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Lymphadenopathy Palpable
Item
palpable adenopathies present
boolean
C0497156 (UMLS CUI [1,1])
C0522499 (UMLS CUI [1,2])
HER2-positive carcinoma of breast Evidence of
Item
her2/neu-positive disease, as evidenced by either of the following:
boolean
C1960398 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
ERBB2 Protein Overexpression Immunohistochemistry
Item
her2/neu overexpression (3+) by immunohistochemistry (ihc)
boolean
C1515560 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
HER2 gene amplification Fluorescent in Situ Hybridization
Item
her2/neu amplification by fluorescence in situ hybridization (fish)
boolean
C1512127 (UMLS CUI [1,1])
C0162789 (UMLS CUI [1,2])
Neoplasm Metastasis Plain chest X-ray | Ultrasonography of liver | Radioisotope scan of bone
Item
no metastatic disease by chest radiography, hepatic ultrasound, and bone scan (metastatic bone series if no nuclear medicine is available)
boolean
C0027627 (UMLS CUI [1,1])
C0039985 (UMLS CUI [1,2])
C0412534 (UMLS CUI [2])
C0203668 (UMLS CUI [3])
Hormone Receptor Status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Estrogen Receptor Status Known | Progesterone Receptor Status Known
Item
estrogen receptor and/or progesterone receptor status known
boolean
C0034804 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205309 (UMLS CUI [1,3])
C0034833 (UMLS CUI [2,1])
C0449438 (UMLS CUI [2,2])
C0205309 (UMLS CUI [2,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Premenopausal state | Postmenopausal state
Item
premenopausal or postmenopausal
boolean
C0232969 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
WHO performance status scale
Item
who performance status 0-2
boolean
C1298650 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Liver function | Renal function | Hematologic function
Item
normal hepatic, renal, and hematological function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0221130 (UMLS CUI [3])
Left ventricular ejection fraction Nuclear medicine procedure | Echocardiography
Item
lvef ≥ 55% by nuclear medicine study or echocardiogram
boolean
C0428772 (UMLS CUI [1,1])
C0203634 (UMLS CUI [1,2])
C0013516 (UMLS CUI [2])
Malignant Neoplasms | Carcinoma in situ of uterine cervix
Item
no prior history of cancer, except carcinoma in situ of the cervix
boolean
C0006826 (UMLS CUI [1])
C0851140 (UMLS CUI [2])
Paclitaxel allergy | Hypersensitivity trastuzumab | Hypersensitivity Herceptin
Item
no allergic reaction or hypersensitivity to paclitaxel and/or trastuzumab (herceptin®)
boolean
C0570707 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0728747 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0338204 (UMLS CUI [3,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
cancer treatment
Item
no prior cancer therapy
boolean
C0920425 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video